These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11382156)

  • 1. [Reversion of cancer and mitochondrial filamentation].
    Gosálvez Gosálvez M
    An R Acad Nac Med (Madr); 2000; 117(4):825-34. PubMed ID: 11382156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the irreproducibility of thioproline.
    Gosalvez M
    Biomed Pharmacother; 1982; 36(8-9):387-8. PubMed ID: 7182022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.
    Kluza J; Marchetti P; Gallego MA; Lancel S; Fournier C; Loyens A; Beauvillain JC; Bailly C
    Oncogene; 2004 Sep; 23(42):7018-30. PubMed ID: 15273722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Respiration of wheat root cells under simultaneous inhibition of parts I and III of the electron transport chain of mitochondria by rotenone and antimycine A].
    Rakhmatullina DF; Gordon LKh; Ogorodnikova TI
    Tsitologiia; 2005; 47(3):230-6. PubMed ID: 16706167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum.
    Leng A; Feldon J; Ferger B
    Synapse; 2003 Dec; 50(3):240-50. PubMed ID: 14515342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of cancer energy metabolism.
    Rodríguez-Enríquez S; Marín-Hernández A; Gallardo-Pérez JC; Carreño-Fuentes L; Moreno-Sánchez R
    Mol Nutr Food Res; 2009 Jan; 53(1):29-48. PubMed ID: 19123180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles.
    Shedden K; Xie XT; Chandaroy P; Chang YT; Rosania GR
    Cancer Res; 2003 Aug; 63(15):4331-7. PubMed ID: 12907600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern molecular approaches to drug design and discovery.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):2-3. PubMed ID: 18193819
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting mitochondria emerges as therapeutic strategy.
    Garber K
    J Natl Cancer Inst; 2005 Dec; 97(24):1800-1. PubMed ID: 16368937
    [No Abstract]   [Full Text] [Related]  

  • 10. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells.
    Shamoto-Nagai M; Maruyama W; Kato Y; Isobe K; Tanaka M; Naoi M; Osawa T
    J Neurosci Res; 2003 Nov; 74(4):589-97. PubMed ID: 14598303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria as targets for cancer chemotherapy.
    Gogvadze V; Orrenius S; Zhivotovsky B
    Semin Cancer Biol; 2009 Feb; 19(1):57-66. PubMed ID: 19101636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase pi localizes in mitochondria and protects against oxidative stress.
    Goto S; Kawakatsu M; Izumi S; Urata Y; Kageyama K; Ihara Y; Koji T; Kondo T
    Free Radic Biol Med; 2009 May; 46(10):1392-403. PubMed ID: 19269317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
    Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
    J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological significance of cancer: mitochondria as a cause of cancer and the inhibition of glycolysis with citrate as a cancer treatment.
    Halabe Bucay A
    Med Hypotheses; 2007; 69(4):826-8. PubMed ID: 17368752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
    Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A
    J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-delta.
    Kurosu T; Tsuji K; Kida A; Koyama T; Yamamoto M; Miura O
    Oncogene; 2007 May; 26(21):2975-87. PubMed ID: 17130834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of menadione and its derivative on cultured cardiomyocytes with mitochondrial disorders.
    Shneyvays V; Leshem D; Shmist Y; Zinman T; Shainberg A
    J Mol Cell Cardiol; 2005 Jul; 39(1):149-58. PubMed ID: 15893762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial activation and the pyruvate paradox in a human cell line.
    de Andrade PB; Casimir M; Maechler P
    FEBS Lett; 2004 Dec; 578(3):224-8. PubMed ID: 15589824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.